Fingerprint
Dive into the research topics of 'Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Zachary Quinn, Benjamin Leiby, Guru Sonpavde, Atish D. Choudhury, Christopher Sweeney, David Einstein, Russell Szmulewitz, Oliver Sartor, Karen Knudsen, Eddy Shih Hsin Yang, Wm Kevin Kelly
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations